Menu

Imperial Innovations' portfolio of companies

Imperial Innovations has a portfolio made up of 98 companies (as at 31 January 2015) covering a range of sectors, but primarily in the areas of therapeutics, medtech, engineering and ICT. Innovations manages its portfolio of companies actively, taking a seat on the board of companies it invests in and providing guidance on management recruitment, intellectual property strategy and overall company development.

The top 20 companies in Imperial Innovations portfolio by value represent 92% of the total value of the portfolio. This top group of companies, in addition to newly founded and seed-funded companies and the remainder of our accelerated growth portfolio, is the primary focus of our active portfolio management.

Top 20 companies by value


Company

Net Investment Carrying Value* (£ '000)

% issued share capital held*

Circassia 79,750 9.3%
Nexeon 34,086 39.3%
PsiOxus Therapeutics 22,623 27.9%
Cell Medica 21,073 27.0%
Veryan Holdings 20,893 48.2%
Abzena plc 17,773 23.4%
Yoyo Wallet 9,513 51.4%
Plaxica 9,446 45.7
Oxford Immunotec Global plc 8,775 4.6
Autifony 8,560 26.9
Cortexica Vision Systems 7,728 30.0
Abingdon Health 7,717 33.7%
TopiVert Pharma 7,543 30.6%
Featurespace 6,789 37.5%
Crescendo Biologics 6,500 22.7
Econic Technologies 6,145 56.1
MISSION Therapeutics 6,012 21.2%
Kesios Therapeutics 4,602 51.4%
Pulmocide 3,500 25.0%
Impression Technologies 3,261 59.1

*All figures are correct as of January 31st 2015